Summit Trail Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
45,877
+14,048
+44% +$862K 0.03% 517
2026
Q1
$2.08M Buy
31,829
+6,584
+26% +$482K 0.03% 496
2025
Q4
$2.03M Buy
25,245
+1,633
+7% +$131K 0.04% 392
2025
Q3
$1.94M Buy
+23,612
New +$2.05M 0.03% 464
2018
Q3
Sell
-355
Closed -$24K 326
2018
Q2
$24K Buy
+355
New +$23.9K 0.01% 368
2018
Q1
Sell
-175
Closed -$12K 762
2017
Q4
$12K Buy
+175
New +$11.4K ﹤0.01% 1170

Other funds holding DOX

Summit Trail Advisors's DOX Position: Q2 2026 in Review

Summit Trail Advisors increased its Amdocs (DOX) stake by 44% in Q2 2026, buying an estimated $862K and bringing the position to 45,877 shares worth $2.32M. The position accounts for 0.03% of the portfolio, ranked #517.

Summit Trail Advisors first reported a position in DOX in Q4 2017 and has held it in 6 quarters since. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Summit Trail Advisors held 45,877 shares of Amdocs worth $2.32M as of Q2 2026.
  • Summit Trail Advisors bought 14,048 Amdocs shares in Q2 2026, an estimated $862K.
  • Amdocs made up 0.03% of Summit Trail Advisors's portfolio in Q2 2026, its #517 holding.
  • Summit Trail Advisors first reported a position in Amdocs in Q4 2017 and has held it in 6 quarters since.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.